12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, health care stocks showed significant movement. Cyclacel Pharmaceuticals, GeneDx Hldgs, BioRestorative Therapies, Vaccinex, Addex Therapeutics, and Tenet Healthcare were among the gainers, with notable increases in their stock prices. On the other hand, SHL Telemedicine, Nektar Therapeutics, GlucoTrack, GE HealthCare Techs, Virios Therapeutics, and 180 Life Sciences experienced declines. The movements were influenced by factors such as Q1 earnings reports for some companies.
April 30, 2024 | 12:06 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
GE HealthCare Techs shares declined 7.81% to $82.0 after their Q1 earnings report, with a market cap of $37.4 billion.
The decline post-Q1 earnings indicates potential investor concerns or unmet expectations, likely affecting short-term stock performance negatively.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 95
POSITIVE IMPACT
Cyclacel Pharmaceuticals stock surged 50.0% to $2.04, with a market cap of $2.6 million.
The significant surge in CYCC's stock price could attract investor interest, potentially leading to short-term price volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
GeneDx Hldgs shares increased 43.54% to $15.79 following their Q1 earnings report, with a market cap of $411.3 million.
Positive reaction to the Q1 earnings report suggests strong investor confidence, likely leading to continued short-term upward momentum.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 95